Search

Search Constraints

You searched for: Author/Creator Cadranel, Jacques

Search Results

2. ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice?. Issue 2 (February 2014)

3. Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial. (August 2021)

4. Characteristics and outcomes of chronic pulmonary aspergillosis: a retrospective analysis of a tertiary hospital registry. (17th February 2014)

5. Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study. (August 2016)

6. Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study. (August 2016)

7. Characterization of lung cancers in patients with BRCA germline variants: A multicenter series. (November 2022)

8. Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options. Issue 2 (23rd October 2018)

9. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Issue 1 (23rd December 2015)

10. Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA). (July 2021)